These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28222522)

  • 1. Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition.
    Rhea EM; Humann SR; Nirkhe S; Farr SA; Morley JE; Banks WA
    J Alzheimers Dis; 2017; 57(1):241-252. PubMed ID: 28222522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition.
    Salameh TS; Bullock KM; Hujoel IA; Niehoff ML; Wolden-Hanson T; Kim J; Morley JE; Farr SA; Banks WA
    J Alzheimers Dis; 2015; 47(3):715-28. PubMed ID: 26401706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice.
    Rhea EM; Nirkhe S; Nguyen S; Pemberton S; Bammler TK; Beyer R; Niehoff ML; Morley JE; Farr SA; Banks WA
    J Alzheimers Dis; 2019; 71(4):1361-1373. PubMed ID: 31561374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
    Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
    Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia].
    Kamei N
    Yakugaku Zasshi; 2017; 137(10):1247-1253. PubMed ID: 28966266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
    Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
    Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy.
    Kamei N; Shingaki T; Kanayama Y; Tanaka M; Zochi R; Hasegawa K; Watanabe Y; Takeda-Morishita M
    Mol Pharm; 2016 Mar; 13(3):1004-11. PubMed ID: 26795701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal insulin in Alzheimer's disease: Food for thought.
    Chapman CD; Schiöth HB; Grillo CA; Benedict C
    Neuropharmacology; 2018 Jul; 136(Pt B):196-201. PubMed ID: 29180222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes.
    Subramanian S; John M
    Indian J Exp Biol; 2012 Jan; 50(1):41-4. PubMed ID: 22279939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction.
    Kamei N; Okada N; Ikeda T; Choi H; Fujiwara Y; Okumura H; Takeda-Morishita M
    Sci Rep; 2018 Dec; 8(1):17641. PubMed ID: 30518944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.
    Rajasekar N; Nath C; Hanif K; Shukla R
    Mol Neurobiol; 2017 Oct; 54(8):6507-6522. PubMed ID: 27730514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Insulin for Alzheimer's Disease.
    Hallschmid M
    CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice.
    Kim BH; Kelschenbach J; Borjabad A; Hadas E; He H; Potash MJ; Nedelcovych MT; Rais R; Haughey NJ; McArthur JC; Slusher BS; Volsky DJ
    AIDS; 2019 May; 33(6):973-984. PubMed ID: 30946151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
    Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
    Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
    Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS
    JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Targeting the brain through the nose. Effects of intranasally administered insulin].
    Brünner YF; Benedict C; Freiherr J
    Nervenarzt; 2013 Aug; 84(8):949-54. PubMed ID: 23760596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease.
    Robinson A; Lubitz I; Atrakchi-Baranes D; Licht-Murava A; Katsel P; Leroith D; Liraz-Zaltsman S; Haroutunian V; Beeri MS
    J Mol Neurosci; 2019 Apr; 67(4):504-510. PubMed ID: 30635783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The brain as an insulin-sensitive metabolic organ.
    Milstein JL; Ferris HA
    Mol Metab; 2021 Oct; 52():101234. PubMed ID: 33845179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease.
    Kazkayasi I; Telli G; Nemutlu E; Uma S
    Life Sci; 2022 Jun; 299():120538. PubMed ID: 35395244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.